The Central Commission for Discipline Inspection again issued a document to name medical corruption, pharmaceutical rebates to build a comprehensive governance system ...

On November 10, the State Supervision Commission of the Central Commission for Discipline Inspection published an article on "Promoting the Health care industry in a multi-pronged effort" in the "Comments" section.
comment pointed out that the collection of high-value consumables to reduce product prices is to continue to deepen the reform of the centralized procurement system of pharmaceutical supplies for patients to bring benefits, but also a multi-pronged effort to promote the medical industry, one of the important measures to clean up the air.
drug, supplies, equipment rebates, pharmaceutical representatives and secondary dealers bribery has been a high-risk area of pharmaceutical bribery cases.
we do to deal with disciplinary violations in the medical field? The article points out that efforts should be made in the system and governance to strengthen the restriction and supervision of the operation of power, and to promote the construction of a comprehensive governance system in a multi-pronged manner: the national medical and health industry is carrying out special actions in the construction of style, focusing on punishing the use of positions to facilitate the receipt of red envelopes and other improper acts, severely crack down on the collection of kickbacks illegal violations, serious investigation and punishment of medical products in medical institutions illegal marketing practices.
The State Health Insurance Administration issued the Guidance on the Establishment of a Credit Evaluation System for Pharmaceutical Prices and Recruitment, and pharmaceutical enterprises involved in seven types of disrelieving acts, such as commercial bribery of medicines, will be included in the "black list" of disrelieving.
Supreme People's Court and the State Health Insurance Administration signed the Memorandum of Cooperation on the Exchange and Sharing of Information on Commercial Bribery Cases in the Pharmaceutical Field, established a regular notification system, and continuously deepened cooperation in the management of commercial bribery in the pharmaceutical field.
multi-sector linkage, playing a series of combination punches, aimed at rooting out the pharmaceutical bidding or procurement process in the process of profit transmission, covert operation, false price increases and other outstanding issues.
reform of the procurement mechanism is an important measure of source governance.
volume procurement by the state to pharmaceutical companies directly tender, the winning drug enterprise price linked, small profits and more sales, in the middle of the savings of huge sales costs, to promote the price back to a reasonable level.
three years since the introduction of mass procurement, the average price reduction of the selected drugs has reached 54%.
to this high-value medical supplies collection in the crown vein bracket, most enterprises reported more than 700 yuan price, has fully considered the cost and profit level of enterprises.
between the price and the past 13,000 yuan, is actually in the past in the sales link to increase the "water", but also very easy to trigger violations of the "grey space."
with the continuous promotion of reform measures and the landing of regulatory policies, the adverse effects of the old sales model on the development of the medical industry will be greatly reduced, pharmaceutical enterprises to fight quality, research and development, innovation is the right way.
this year, the National Health and Health Commission, the Central Commission for Discipline Inspection on medical corruption intensive text.
This "multi-pronged efforts to promote the health care industry clean air" is the eighth time this year, the Central Commission for Discipline Inspection issued an article stressing the fight against medical corruption: October 17, the Central Commission for Discipline Inspection website published "strict investigation of power and money transactions, the establishment of a list of misin confidence, centralized procurement, cut off the medical bribery interest chain" article, the content refers directly to the medical representatives and medical institutions of improper transactions.
September 2, the Central Commission for Discipline Inspection, the State Supervision Commission website published "to take the case as a mirror Chengdu serious treatment of corruption in the medical field" article shows that Chengdu Longquan District, the first people's hospital, the former director of the equipment supplies section to take advantage of the convenience of his position, to take illegal methods for the relevant personnel in the supply of drugs, equipment procurement and other aspects of profit, accept bribes of more than 680,000 yuan.
August 16, the official website of the Central Commission for Discipline Inspection and the State Supervision Commission published an article on "Tibet's discipline inspection and supervision organs to accurately consult and remove corruption lesions in the medical field".
article pointed out that the joint investigation team of the Tibet Autonomous Region Commission for Discipline Inspection found that "corruption in the medical field is relatively concentrated, mainly in the purchase and sale of medicines, hospital infrastructure, medical insurance funds management and use."
August 14th, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published an article entitled "Anti-corruption three-person talk about the discipline inspection and supervision group of the Health and Safety Commission: strengthening political supervision and strictly investigating violations of discipline and law", calling for the capture of corruption, the official publication of the focus of supervision in the medical field: first, corruption, and second, the issue of fraud and insurance.
August 4, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published "Focus areas of positive wind anti-corruption observation deep investigation of medical corruption", said that the medical field should be resolutely investigated and punished serious violations of discipline.
the first half of this year disclosed in the medical field corruption cases, the collection of drug supplies rebates is the most frequent problem, the amount involved in the case remains high, the chain of corrupt interests is chained together.
June 27, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published the article "Observation | How to deal with bribery in the field of medicine, bribery and bribery together", which refers directly to the pharmaceutical industry to recover deductions, take commissions, thank you fees and other acts.
article shows that there are pharmaceutical representatives frankly, with the drug price of about 45% rebate, solicited in the hospital has a relationship with the secondary agents to open sales channels.
April 3, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published an article on "Trafficking in Pharmaceutical Data, Secretly Making Drug Generations", revealing the profit-making case involving Wang Xiaojun, a former pharmacy staff member of the First People's Hospital in Yanxian County, Zhejiang Province.
corruption and corruption in the medical field, has been the focus of the anti-corruption crackdown.
The amount involved is high, the chain of corrupt interests is chained together, a large number of disclosed corruption cases in the medical field, the collection of drug supplies rebate problem appears the most frequently, resulting in high prices of drugs and medical supplies, medical costs too fast growth, the loss of health insurance funds and other issues.
reports of medical rebates across the country continue to appear, and the national medical anti-corruption efforts continue to strengthen.
With the advance of national procurement, the development of tax verification in the pharmaceutical industry, as well as the two-vote system, health insurance fee control policy, coupled with a strict investigation of drugs, equipment supplies rebates, and crack down on medical corruption, the traditional drug marketing methods that used to rely on high pricing and channel space to drive sales will be completely subverted.
high-pressure market environment and huge conflicts of interest, the pharmaceutical industry will be full of whistle-blowing letters, pharmaceutical companies must be timely transformation.